Gene
CHPF2
chondroitin polymerizing factor 2
Explore in graph →CI-GENE-00041296HGNC:29270 ENSG00000033100 NCBI 54480 Approved
Curated evidence
Clinical evidence (0)
CIViC items involving this gene, grouped by molecular profile and therapy, with native levels and directions. 50 items per page.
Data not yet available
No curated evidence item involves this gene yet.
Cohorts
Alteration frequency by cohort (5)
Frequency = cases affected / cases profiled within one cohort. Cohorts are never pooled.
gdcProvenance
- Source
- NCI Genomic Data Commons (open aggregated data)
- Dataset
- GDC top mutated genes by project
- Version
- Data Release 46.0
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- cohort
- License
- Open-access GDC data (NCI); citation of GDC and originating program requested
- Run
- ING-GDC-20260908-000001
| Cohort | Mapped cancer | Alteration | Affected (n) | Profiled (n) | Frequency (%) | Rank in cohort | Source |
|---|---|---|---|---|---|---|---|
| Refractory Cancers (RC) - Peripheral T-Cell Lymphoma (PTCL) RC-PTCL | Peripheral T-Cell Lymphoma, Not Otherwise Specified | Ssm | 14 | 58 | 24.1% | 73 | gdc |
| Primary Central Nervous System Lymphoma (Mayo Clinic, Clin Cancer Res 2015) pcnsl_mayo_2015 | Primary Central Nervous System Lymphoma | Ssm | 2 | 10 | 20% | 29 | cbioportal |
| Cholangiocarcinoma (National Cancer Centre of Singapore, Nat Genet 2013) chol_nccs_2013 | Cholangiocarcinoma | Ssm | 1 | 15 | 6.7% | 41 | cbioportal |
| Neuroendocrine Prostate Cancer (Multi-Institute, Nat Med 2016) nepc_wcm_2016 | Prostate Adenocarcinoma | Ssm | 5 | 114 | 4.4% | 68 |
Literature
Linked publications (0)
Data not yet available
No publication linked to this gene yet.